Under construction – not a live service
Sign in
CompletedNo phase

TipTraQ Home Sleep Test Validation Study, Duke

Key facts

Who runs it
PranaQ Pte. Ltd.
Where
Durham, United StatesSee the site
Trial code
Status
Completed
People taking part
200 people enrolled
Started
28 Feb 2024
Ended
23 Aug 2024
Type of study
Observational
Record updated
22 October 2024

Who can take part

Age
20 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Subjects from the age of 20 and older that have an indication for an in-lab PSG study in the Duke University Hospital. The subject should be able to understand the study and sign the informed consent before being enrolled in the study. During the study period, the subject can withdraw from the study anytime

Who cannot take part

  • Chronic opioid medication user Devastating Severe strokes, with the modified Rankin score (mRS)≥4
  • Subjects with the following medical conditions will be excluded from this study:
  • Heart transplant
  • Heart failure, New Youk Heart Association (NYHA) classification III or IV
  • Chronic Obstructive Lung Disease, Global Initiative for Chronic Obstructive Lung Disease (GOLD) categorization 3 or 4
  • Tracheostomy
  • Incapable of comprehending and signing the informed consent and questionnaires, including but not limited to subjects with severe Alzheimer's, unconscious by head trauma, or of someone with limited mental capacity
  • Cannot correctly follow the order to use the TipTraQ device

Where in United States

  • Duke UniversityDurham, United StatesNo longer taking part

About the trial

What the trial wants to find out

A validation study has been designed to assess the performance of a home sleep test device, TipTraQ, for screening sleep apnea. The study involves participants wearing the TipTraQ device on their fingertip during a traditional sleep test, known as polysomnography (PSG), conducted in a sleep center. The performance of the device will then be evaluated by comparing the results from the TipTraQ system with those from the traditional sleep test.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Validation of a Medical-grade Wearable Device with Interpretable Artificial Intelligence System for the Obstructive Sleep Apnea-hypopnea Syndrome (OSAHS) Screening
Record updated
22 October 2024